Clinical Trial

Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis

Study acronym: EMPHASIS-2
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to assess the efficacy and safety of minocycline in improving functional outcome among patients with acute ischaemic stroke receiving intravenous thrombolysis.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-02
critical Primary endpoint(s) modified 2026-04-18
Trial Details
NCT Number NCT07526987
Lead Sponsor Beijing Tiantan Hospital
Conditions Ischaemic Stroke
Enrollment 934 participants
Start Date 2026-06-05
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01